  Major depressive disorder is a widespread mood disorder. One of the most
debilitating symptoms patients often experience is cognitive impairment. Recent
findings suggest that inflammation is associated with depression and impaired
cognition. Pro-inflammatory cytokines are elevated in the blood of depressed
patients and impair learning and memory processes, suggesting that an
anti-inflammatory approach might be beneficial for both depression and
cognition. Utilizing the learned helplessness paradigm, we first established a
mouse model of depression in which learning and memory are impaired. We found
that learned helplessness (LH) impaired novel object recognition (NOR) and
spatial working memory. LH mice also exhibited reduced hippocampal dendritic
spine density and increased microglial activation compared to non-shocked (NS)
mice or mice that were subjected to the learned helpless paradigm but did not
exhibit learned helplessness (non-learned helpless, or NLH). These effects were
mediated by microglia, as treatment with PLX5622, which depletes microglia and
macrophages, restored learning and memory and hippocampal dendritic spine
density in LH mice. However, PLX5622 also impaired learning and memory and
reduced hippocampal dendritic spine density in NLH mice, suggesting that
microglia in NLH mice are involved in the production of molecules that promote
learning and memory. We found that microglial interleukin (IL)-10 levels were
reduced in LH mice and IL-10 administration was sufficient to restore NOR,
spatial working memory, and hippocampal dendritic spine density in LH mice, and
in NLH mice treated with PLX5622, consistent with a pro-cognitive role for
IL-10. Altogether, these data demonstrate the critical role of IL-10 in
promoting learning and memory after learned helplessness.
